Priority 3 from the Sight Loss and Vision PSP Age Related Macular Degeneration
UNCERTAINTY: How can age related macular degeneration (AMD) be prevented? (JLA PSP Priority 3) | |
---|---|
Overall ranking | 3 |
JLA question ID | 0014a/3 |
Explanatory note | No relevant systematic reviews identified at the time of the PSP |
Evidence | No evidence found at the time of the PSP |
Health Research Classification System category | Eye |
Extra information provided by this PSP | |
---|---|
Original uncertainty examples | None provided |
Systematic reviews that need updating or extending | None identified |
Systematic reviews in preparation (at time of PSP) | None identified |
Ongoing controlled trials | Genetics and Markers of Degenerative and Inflammatory Eye Diseases NCT00647439 |
Submitted by | Patients |
Outcomes to be measured | Incidence of AMD: change in symptoms; adverse effects or complications; acceptability to the patient; and cost |
PSP information | |
---|---|
PSP unique ID | 0014a |
PSP name | Sight Loss and Vision - Age Related Macular Degeneration |
Total number of uncertainties identified by this PSP. | 113 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
Date of priority setting workshop | April and May 2013 |